{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:03:22Z","timestamp":1789027402592,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00109-024-02477-x","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T20:18:57Z","timestamp":1723580337000},"page":"1199-1215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["WNT2B high\u2011expressed fibroblasts induce the fibrosis of IBD by promoting NK cells secreting IL-33"],"prefix":"10.1007","volume":"102","author":[{"given":"Yanling","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhe","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-0616","authenticated-orcid":false,"given":"Sitang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"2477_CR1","doi-asserted-by":"publisher","first-page":"7247238","DOI":"10.1155\/2019\/7247238","volume":"2019","author":"Q Guan","year":"2019","unstructured":"Guan Q (2019) A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019:7247238","journal-title":"J Immunol Res"},{"issue":"1","key":"2477_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA (2019) Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc 94(1):155\u2013165","journal-title":"Mayo Clin Proc"},{"key":"2477_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhang S (2020) T Cells in Fibrosis and Fibrotic Diseases. Front Immunol 11:1142","journal-title":"Front Immunol"},{"issue":"1","key":"2477_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/00365521.2014.968863","volume":"50","author":"G Latella","year":"2015","unstructured":"Latella G et al (2015) Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J Gastroenterol 50(1):53\u201365","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"2477_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.physiol.70.113006.100646","volume":"73","author":"DW Powell","year":"2011","unstructured":"Powell DW et al (2011) Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol 73(1):213\u2013237","journal-title":"Annu Rev Physiol"},{"issue":"24","key":"2477_CR6","first-page":"8839","volume":"22","author":"A Vetuschi","year":"2018","unstructured":"Vetuschi A et al (2018) PPAR-\u03b3 with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD. Eur Rev Med Pharmacol Sci 22(24):8839\u20138848","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2477_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.12974","volume":"302","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 302(1):211\u2013227","journal-title":"Immunol Rev"},{"issue":"1","key":"2477_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-041818-011649","volume":"71","author":"SA Cook","year":"2020","unstructured":"Cook SA, Schafer S (2020) Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation. Annu Rev Med 71(1):263\u2013276","journal-title":"Annu Rev Med"},{"issue":"7","key":"2477_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F et al (2019) Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20(7):928\u2013942","journal-title":"Nat Immunol"},{"key":"2477_CR10","doi-asserted-by":"crossref","unstructured":"Wei K, Nguyen HN, Brenner MB (2021) Fibroblast pathology in inflammatory diseases. J Clin Invest 131(20):e149538","DOI":"10.1172\/JCI149538"},{"issue":"5","key":"2477_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2019.10.027","volume":"179","author":"B Huang","year":"2019","unstructured":"Huang B et al (2019) Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways. Cell 179(5):1160-1176.e24","journal-title":"Cell"},{"key":"2477_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.matbio.2017.11.010","volume":"68\u201369","author":"M Mack","year":"2018","unstructured":"Mack M (2018) Inflammation and fibrosis. Matrix Biol 68\u201369:106\u2013121","journal-title":"Matrix Biol"},{"key":"2477_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/978-1-60761-362-6_32","volume":"612","author":"SL Sanos","year":"2010","unstructured":"Sanos SL, Diefenbach A (2010) Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol Biol 612:505\u2013517","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2477_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ecco-jcc\/jjab014","volume":"15","author":"BV Zaiatz","year":"2021","unstructured":"Zaiatz BV et al (2021) Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients. J Crohns Colitis 15(8):1316\u20131325","journal-title":"J Crohns Colitis"},{"key":"2477_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3389\/fimmu.2019.00961","volume":"10","author":"A Poggi","year":"2019","unstructured":"Poggi A et al (2019) Human Gut-Associated Natural Killer Cells in Health and Disease. Front Immunol 10:961","journal-title":"Front Immunol"},{"issue":"49","key":"2477_CR16","doi-asserted-by":"publisher","first-page":"20847","DOI":"10.1073\/pnas.0906481106","volume":"106","author":"M Balsamo","year":"2009","unstructured":"Balsamo M et al (2009) Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 106(49):20847\u201320852","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2477_CR17","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1038\/s41598-019-52239-w","volume":"9","author":"B Greb-Markiewicz","year":"2019","unstructured":"Greb-Markiewicz B et al (2019) The subcellular localization of bHLH transcription factor TCF4 is mediated by multiple nuclear localization and nuclear export signals. Sci Rep 9(1):15629","journal-title":"Sci Rep"},{"issue":"7","key":"2477_CR18","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S et al (2017) Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc 12(7):1295\u20131309","journal-title":"Nat Protoc"},{"issue":"6","key":"2477_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"178","author":"JC Martin","year":"2019","unstructured":"Martin JC et al (2019) Single-Cell Analysis of Crohn\u2019s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell 178(6):1493-1508.e20","journal-title":"Cell"},{"issue":"7","key":"2477_CR20","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjaa009","volume":"14","author":"MC Barnhoorn","year":"2020","unstructured":"Barnhoorn MC et al (2020) Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease. J Crohns Colitis 14(7):995\u20131009","journal-title":"J Crohns Colitis"},{"issue":"3","key":"2477_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2016.11.040","volume":"168","author":"R Nowarski","year":"2017","unstructured":"Nowarski R, Jackson R, Flavell RA (2017) The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier. Cell 168(3):362\u2013375","journal-title":"Cell"},{"issue":"2","key":"2477_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","volume":"175","author":"J Kinchen","year":"2018","unstructured":"Kinchen J et al (2018) Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell 175(2):372-386.e17","journal-title":"Cell"},{"key":"2477_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clim.2016.12.004","volume":"175","author":"S Yusung","year":"2017","unstructured":"Yusung S et al (2017) NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn\u2019s disease patients. Clin Immunol 175:82\u201390","journal-title":"Clin Immunol"},{"issue":"1","key":"2477_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2036.2010.04499.x","volume":"33","author":"AW Steel","year":"2011","unstructured":"Steel AW et al (2011) Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. Aliment Pharmacol Ther 33(1):115\u2013126","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2477_CR25","doi-asserted-by":"publisher","first-page":"a011163","DOI":"10.1101\/cshperspect.a011163","volume":"4","author":"R Nusse","year":"2012","unstructured":"Nusse R (2012) Wnt signaling. Cold Spring Harb Perspect Biol 4(5):a011163","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2477_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10620-007-9973-3","volume":"53","author":"J You","year":"2008","unstructured":"You J et al (2008) Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci 53(4):1013\u20131019","journal-title":"Dig Dis Sci"},{"key":"2477_CR27","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S (2020) WNT\/\u03b2-catenin signaling in the development of liver cancers. Biomed Pharmacother 132:110851","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2477_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 7(1):3","journal-title":"Signal Transduct Target Ther"},{"issue":"36","key":"2477_CR29","doi-asserted-by":"publisher","first-page":"14962","DOI":"10.1073\/pnas.1100513108","volume":"108","author":"K Ohta","year":"2011","unstructured":"Ohta K et al (2011) Tsukushi functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to transmembrane protein Frizzled4. Proc Natl Acad Sci U S A 108(36):14962\u201314967","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2477_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ecco-jcc\/jjz134","volume":"14","author":"D Ortiz-Masi\u00e0","year":"2020","unstructured":"Ortiz-Masi\u00e0 D et al (2020) WNT2b Activates Epithelial-mesenchymal Transition Through FZD4: Relevance in Penetrating Crohn\u00b4s Disease. J Crohns Colitis 14(2):230\u2013239","journal-title":"J Crohns Colitis"},{"key":"2477_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2017.06.017","volume":"100","author":"Z Hodzic","year":"2017","unstructured":"Hodzic Z et al (2017) IL-33 and the intestine: The good, the bad, and the inflammatory. Cytokine 100:1\u201310","journal-title":"Cytokine"},{"key":"2477_CR32","doi-asserted-by":"publisher","first-page":"781012","DOI":"10.3389\/fphys.2021.781012","volume":"12","author":"M Kurimoto","year":"2021","unstructured":"Kurimoto M et al (2021) IL-33 as a Critical Cytokine for Inflammation and Fibrosis in Inflammatory Bowel Diseases and Pancreatitis. Front Physiol 12:781012","journal-title":"Front Physiol"},{"issue":"10","key":"2477_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT (2008) The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7(10):827\u2013840","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2477_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479\u2013490","journal-title":"Immunity"},{"key":"2477_CR35","doi-asserted-by":"crossref","unstructured":"De Salvo C et al (2021) NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis. J Clin Invest 131(5):e140624","DOI":"10.1172\/JCI140624"},{"issue":"13","key":"2477_CR36","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1073\/pnas.1418549112","volume":"112","author":"C Baumann","year":"2015","unstructured":"Baumann C et al (2015) T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses. Proc Natl Acad Sci U S A 112(13):4056\u20134061","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2477_CR37","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1073\/pnas.0912678107","volume":"107","author":"L Pastorelli","year":"2010","unstructured":"Pastorelli L et al (2010) Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis. Proc Natl Acad Sci U S A 107(17):8017\u20138022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2477_CR38","doi-asserted-by":"publisher","first-page":"14879","DOI":"10.1038\/s41598-020-71848-4","volume":"10","author":"K Minaga","year":"2020","unstructured":"Minaga K et al (2020) Identification of serum IFN-\u03b1 and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease. Sci Rep 10(1):14879","journal-title":"Sci Rep"},{"issue":"5","key":"2477_CR39","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/mi.2015.144","volume":"9","author":"T Watanabe","year":"2016","unstructured":"Watanabe T et al (2016) Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis. Mucosal Immunol 9(5):1234\u20131249","journal-title":"Mucosal Immunol"},{"key":"2477_CR40","doi-asserted-by":"crossref","unstructured":"Georgakis S et al (2021) NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-\u03b1 production in patients with SLE. JCI Insight 6(21):e147671","DOI":"10.1172\/jci.insight.147671"},{"issue":"11","key":"2477_CR41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR (2016) Interleukin-33 in health and disease. Nat Rev Immunol 16(11):676\u2013689","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2477_CR42","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","volume":"62","author":"MA Sedhom","year":"2013","unstructured":"Sedhom MA et al (2013) Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 62(12):1714\u20131723","journal-title":"Gut"},{"key":"2477_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","volume":"415","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett 415:117\u2013128","journal-title":"Cancer Lett"},{"issue":"1","key":"2477_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MPG.0b013e318246be78","volume":"55","author":"TA Willson","year":"2012","unstructured":"Willson TA et al (2012) STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 55(1):32\u201343","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2477_CR45","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2477_CR46","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.intimp.2021.107843","volume":"98","author":"X Guan","year":"2021","unstructured":"Guan X et al (2021) Crosstalk between Wnt\/\u03b2-catenin signaling and NF-\u03baB signaling contributes to apical periodontitis. Int Immunopharmacol 98:107843","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2477_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan Y, Mao R, Yang J (2013) NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4(3):176\u2013185","journal-title":"Protein Cell"},{"issue":"1","key":"2477_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21(1):11\u201319","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"2477_CR49","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1074\/jbc.M210081200","volume":"278","author":"A Hecht","year":"2003","unstructured":"Hecht A, Stemmler MP (2003) Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J Biol Chem 278(6):3776\u20133785","journal-title":"J Biol Chem"},{"issue":"17","key":"2477_CR50","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/bph.14770","volume":"176","author":"Z Wang","year":"2019","unstructured":"Wang Z et al (2019) Salinomycin exerts anti-colorectal cancer activity by targeting the \u03b2-catenin\/T-cell factor complex. Br J Pharmacol 176(17):3390\u20133406","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2477_CR51","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","volume":"182","author":"MF Neurath","year":"1995","unstructured":"Neurath MF et al (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182(5):1281\u20131290","journal-title":"J Exp Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02477-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T18:02:03Z","timestamp":1726941723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2477"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02477-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human study: Based on the declaration of Helsinki as reflected in a prior approval by the institution's human research committee, this study was approved by Guangzhou Women and Children's Medical Center ethics committee. Animal study: All animal experiments were approved by institutional Animal Experiment Committee of Southern Medical University or Nanfang Hospital, and performed at Nanfang Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that there are no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}